Metabolic Syndrome, Chronic Kidney, and Cardiovascular Diseases: Role of Adipokines
Figure 1
Possible dynamic interactions between obesity, CKD, and CVD. The increase of visceral mass determines both decreased production of ADN and increased production of inflammatory adipokines which result in increased insulin resistance.